Literature DB >> 444361

Plasma half-life of clofibric acid in renal failure.

E M Faed, E G McQueen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 444361      PMCID： PMC1429643          DOI： 10.1111/j.1365-2125.1979.tb00956.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Atherosclerosis in patients undergoing maintenance hemodialysis.

Authors:  J D Bagdade
Journal:  Kidney Int Suppl       Date:  1975-02       Impact factor: 10.545

2.  Serum clofibrate concentrations in patients on continuous medication.

Authors:  E M Faed; E G McQueen
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

3.  Control of clofibrate toxicity in uremic hypertriglyceridemia.

Authors:  A P Goldberg; D J Sherrard; L B Haas; J D Brunzell
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875
  3 in total
  8 in total

1.  Impaired elimination of lorazepam following subchronic administration in two patients with renal failure.

Authors:  R K Verbeeck; T B Tjandramaga; P J De Schepper; R Verberckmoes
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

2.  Dosage adjustment in renal insufficiency.

Authors:  G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

Review 3.  Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors:  R K Verbeeck; R A Branch; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

4.  Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.

Authors:  E M Faed
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

5.  The influence of renal insufficiency and haemodialysis on the kinetics of ciprofibrate.

Authors:  N Ferry; N Bernard; N Pozet; E Gardes; G Cuisinaud; M Labeeuw; P Y Zech; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

6.  Influence of food on the absorption of the p-chlorophenolic ester of chlorophenoxyisobutyric acid in man.

Authors:  G Houin; R A Shastri; J Barre; B Pinchon; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

7.  Paracetamol disposition and metabolite kinetics in patients with chronic renal failure.

Authors:  L F Prescott; G C Speirs; J A Critchley; R M Temple; R J Winney
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 8.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.